Amazon Care coming to new markets

E-commerce giant Amazon is bringing its expanding healthcare services to 20 U.S. cities.

Amazon first introduced its healthcare clinics to its employees earlier this year after providing them with virtual care services. Its virtual care app, Amazon Care, lets people connect with physicians online through messages and video, with an option for an in-person visit from a nurse for exams, tests and vaccines. The online retailer offered up its medical services to others outside the company this summer.

Now, Amazon’s medical offering will expand beyond its current footprint of Washington state, Washington, DC, and Baltimore. The news was first reported by Insider. The telehealth and in-person services will soon be available in Philadelphia, Chicago, Boston and Dallas, people familiar with the matter told Insider.

In 2022, Amazon will add another 16 cities in its medical care reach. The cities being targeted for next year include: Atlanta; Denver; Detroit; Houston; Indianapolis; Kansas City, Missouri; Los Angeles; Miami; Minneapolis; Nashville, Tennessee; New York; Phoenix; Pittsburgh; San Francisco; San Jose, California; and St. Louis. However, the locations could change.

In total, about 40,000 people are signed up for Amazon Care, with most being Amazon employees, according to Insider. 

The expansion of Amazon Care comes after the company experienced a healthcare flop in Haven, a joint venture with Berkshire Hathaway and JPMorgan Chase. Haven aimed to improve healthcare coverage for all employees of the three companies but failed to meaningfully affect the healthcare insurance market.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.